Thanks for this. Unfortunately it is only an abstract and thus is a little short on the details (for instance if they excluded people with Covid infections from

Thanks for this. Unfortunately it is only an abstract and thus is a little short on the details (for instance if they excluded people with Covid infections from their cohort). Also it is difficult to assess if a rise in inflammatory markers would still be considered normal for instance when comparing to other vaccines or not. Compare for instance similar publication of influence vaccine https://pubmed.ncbi.nlm.nih.gov/15976761/ https://pubmed.ncbi.nlm.nih.gov/15976761/